IL18 and chronic myelogenous leukemia, BCR-ABL1 positive: The aim of this study is to evaluate the frequency of IL-18 gene promoter polymorphisms in Turkish CLL and CML patient groups and compare them with a control group in order to verify a correlation between the allelic variations and the risk of CML and CLL.